[CBAY] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
06-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -5.89%
YoY- -125.44%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 5,207 -
PBT -24,038 -23,075 -19,449 -18,563 -17,531 -17,005 -5,043 184.04%
Tax 1,610 1,176 1,106 1,453 42 -4,447 -543 -
NP -24,038 -23,075 -19,449 -18,563 -17,531 -17,005 -5,043 184.04%
Tax Rate - - - - - - - -
Total Cost 24,038 23,075 19,449 18,563 17,531 17,005 10,250 76.79%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -96.85 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -0.35 -0.37 -0.31 -0.31 -0.30 -0.32 -0.09 147.91%
EPS Diluted -0.35 -0.37 -0.31 -0.31 -0.30 -0.32 -0.09 147.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.